“difference was apparent”

However, a difference was apparent at the 90 th percentile (β = 231, SE: 96.7, p = 0.018), such that EUC participants were significantly more likely to report NSSI frequencies above this percentile than DBT-A participants.

A significant sex difference was apparent for vigorous physical activity (men: r=0.35 vs women: r=0.55; p=0.02).

Sex differences A significant sex difference was apparent in the rate of progression of cognitive decline as measured by CDR‐SB in untreated NACC AD participants ( P = 0.02) with females associated with more rapid cognitive decline compared to males (Figure 3A , dashed lines).

Comparing the two intervention groups separately against the WLC group, a significant difference was apparent between I A and WLC (χ 2 = 5.549; p = 0.02), but not between I SMS and WLC (χ 2 = 2.203; p = 0.20).

The difference was apparent for patients with LyP-A (40% vs. 11%, P = 0.024), but not LyP-C (44% vs. 50%, P = 1.0).

When we compared overall clubfoot size versus unaffected feet after age matching, a statistical significant difference was apparent (in length; pair 7, p = 0.03 and in width; pair 8, p = 0.02).

After excluding the samples that showed no detectable Mcl-1 expression, a significant difference was apparent between Mcl-1 expression in BM versus PB (p = 0.033).

Ratings for the low- and high- trustworthiness prototypes (stimuli S3 and S7) differed highly significantly with lower average ratings for S3 than S7 (S3: z = -0.39; S7: z = 0.40; paired t-test: t(499) = 14.2, p = 1.38e-38) while no such difference was apparent for control stimuli (S3: z = 0.03; S7:z = -0.09; t(499) = 2.08, p = 0.038 n.s. after Bonferroni correction).

A significant gender difference was apparent in the following: RP (47.30 ± 11.65 in men versus 45.01 ± 12.25 in women, P = 0.040); BP (49.25 ± 10.04 versus 43.58 ± 10.60, P < 0.001); SF (48.83 ± 11.35 versus 45.55 ± 13.13, P = 0.031); and RE (47.95 ± 11.40 versus 43.68 ± 13.08, P = 0.003).

A considerable difference was apparent with average levels of IL-6, 4-fold (p = 0.047), and TNF-α, 5-fold (p = 0.0025), higher in fibroblasts from minipig #175-5 AP relative to the control.

Moreover, whereas a lesser temporal difference persisted with Npas2 and Hlf , no significant difference was apparent for Pcsk4 under fasting conditions ( P ≥ 0.05, Bonferroni's post hoc test).

However, IL-6 potentiated the capsaicin-evoked anti-secretory current in SD rats but not WKY rats such that a significant difference was apparent between the strains ( p < 0.05, Figures 4 C,D).

In group 13-18 the difference was apparent on more subscales: total (p < .05, es = 0.46), physical (p < .05, es = 0.42), psychosocial (p < .05, es = 0.42) and school (p < .05, es = 0.39).

No significant difference was apparent ( p > 0.05).

Moreover, when comparing DIR at day 14 pi and day 21 pi for all three populations, no significant difference was apparent (Chi square test: p > 0.05).

No statistically significant difference was apparent between the groups for either material ( p > 0.05).

buccal sites ( p < 0.05); additionally, a statistically significant difference was apparent between the distal and a combination of buccal and lingual sites ( p < 0.05).

However, the mean ± SD difference was apparent at 9 h post-surgery in the three study groups (TD: 1.4 ± 0.95, BD: 0.4 ± 0.3, and SD: 3.3 ± 2.5; p > 0.05; Figure 2 ).

For males, this difference was apparent only at 48 weeks of age (Genotype x Time: F 4,148 = 3.33, p < .05; pairwise comparisons 48w, p < .001, all others n.s .).

A significant difference was apparent among LDPE‐, PCL‐, and PCL/PPC‐packaged fruits after 4 days of storage ( p < 0.05).

The prognosis of each cohort was compared, and no significant difference was apparent in OS or PFS (P>0.05).

Thus, no significant difference was apparent in the OF lengths between the left side and right sides of either group ( Fig. 5 , P > 0.05).

Both HKA and FTA improved in two groups, and no significant group difference was apparent (P>0.05).

Urine protein levels prior to and following treatment Following treatment, the urine protein level in the spironolactone group had significantly decreased compared with that prior to treatment (P<0.05), whereas no significant difference was apparent in the control group (P>0.05).

Additionally, a considerable difference was apparent in the GA‐CG group compared to the GA group ( p < 0.05) (Figure 5 ). 3.5.